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Abstract
The transition metal, copper (Cu), is an enzymatic cofactor required for a wide range of biochemical processes. Its
essentiality is demonstrated by Menkes disease, an X-linked copper deficiency disorder characterized by defects in nervous-,
cardiovascular- and skeletal systems, and is caused by mutations in the ATP7A copper transporter. Certain ATP7A mutations
also cause X-linked Spinal Muscular Atrophy type 3 (SMAX3), which is characterized by neuromuscular defects absent an
underlying systemic copper deficiency. While an understanding of these ATP7A-related disorders would clearly benefit from
an animal model that permits tissue-specific deletion of the ATP7A gene, no such model currently exists. In this study, we
generated a floxed mouse model allowing the conditional deletion of the Atp7a gene using Cre recombinase. Global
deletion of Atp7a resulted in morphological and vascular defects in hemizygous male embryos and death in utero.
Heterozygous deletion in females resulted in a 50% reduction in live births and a high postnatal lethality. These studies
demonstrate the essential role of the Atp7a gene in mouse embryonic development and establish a powerful model for
understanding the tissue-specific roles of ATP7A in copper metabolism and disease.
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Introduction
The ability of copper to cycle between Cu1+ and Cu2+ oxidation
states enables it to function as a cofactor within a host of enzymes
that catalyze a wide range of biochemical reactions. These include
cellular respiration (cytochrome oxidase), connective tissue forma-
tion (lysyl oxidase), catecholamine synthesis (dopamine b hydrox-
ylase), pigmentation (tyrosinase) and neuropeptide processing
(peptidylglycine a-amidating monooxygenase) [1]. Not surprising-
ly, copper deficiency during gestation results in pleiotropic defects
ranging from early embryonic lethality to long term postnatal
defects in nervous-, circulatory- and skeletal systems [2]. The
consequences of copper deficiency in humans are illustrated by
Menkes disease (OMIM 390400), a pediatric disorder of copper
metabolism caused by mutations in the ATP7A gene
(NM_000052). The affected protein, ATP7A, is a copper
transporting P-type ATPase that is predominantly located in the
distal compartments of the Golgi complex where it loads copper
into the secretory pathway for incorporation into nascent
polypeptides [3,4]. The ATP7A protein also functions in cellular
copper export, which is coupled to copper-stimulated trafficking of
the protein into post-Golgi vesicles that fuse with the plasma
membrane [3].
Menkes disease patients exhibit a wide spectrum of defects that
are attributable to copper deficiency, including connective tissue
malformation giving rise to hemorrhage, neurological symptoms
such as mental retardation and seizures, and hypopigmentation
due to defects in melanin synthesis [1]. Occipital horn syndrome
(OMIM 304150) is another variant of this disorder in which
connective tissue defects predominate with little or no neurological
abnormality [5]. As an X-linked recessive trait, Menkes patients
are typically male, although heterozygous female carriers may
exhibit subtle phenotypes such as mosaic hypopigmentation due to
variation in X-chromosome inactivation [6]. Recently, two
missense mutations in the ATP7A gene were shown to cause X-
linked distal spinal muscular atrophy type 3 (SMAX3; OMIM
300489), a degenerative neuromuscular disorder that typically
affects patients in the second or third decade of life. Although in
vitro studies suggest that SMAX3-causing mutations diminish
ATP7A copper transport activity and localization, a systemic
copper deficiency is lacking in SMAX3 patients suggesting that the
motor neurons may be hypersensitive to subtle perturbations in
copper homeostasis [1,7].
The striking differences between Menkes disease, OHS and
SMAX3, particularly in the affected organs, highlights the need to
understand the functions of ATP7A at a tissue-specific level.
However, there is currently no animal model that allows ATP7A
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deletion to be restricted to a given tissue. Whereas spontaneous
mutations in the Atp7a gene have been identified in the collection
of Mottled mice, named for the variegated coat color of
heterozygous females, these mutants are limited in addressing
the tissue-specific functions of the Atp7a protein due in part to the
fact that Atp7a null mutations are embryonic lethal, as seen in the
Dappled and Tohoku mutants, [8–10]. Thus, the only available
mutants for study are those in which mutations only partially
disrupt Atp7a protein activity (e.g., Brindled or Blotchy mice) [11].
In addition, since the Atp7a gene is ubiquitously expressed, certain
phenotypes in the Mottled mice may be secondary to defects in
copper homeostasis in other tissues. In this study, we describe the
generation of an Atp7a ‘‘floxed’’ mouse model by homologous
integration of Lox P sites into the sequences surrounding exon 11.
Global deletion of the Atp7a gene in male hemizygotes using Cre
recombinase resulted in embryonic lethality and a loss of Atp7a
protein expression. These findings provide unequivocal evidence
that Atp7a is required for embryogenesis and provide a powerful
template for elucidating the spatiotemporal requirements for Atp7a
in vivo.
Results
Generation of a Floxed Atp7a Mouse Model
A targeting construct encompassing exons 8 to 13 of the Atp7a
gene was generated with Lox P sites flanking exon 11. Since this
exon encodes a region of Atp7a protein that is highly conserved
across orthologues of different phyla, its deletion by Cre
recombinase was predicted to result in a nonfunctional protein
(Figure 1). The targeting construct also contained a neomycin
resistance cassette that was driven by the phosphoglycerate kinase
1 promoter and flanked by FLP recombination sites (Figure 1).
Recombinant embryonic stem cells with homologous integration
of the targeting vector were microinjected into Balb/c blastocysts.
The resulting chimeras with a high percentage black coat color
were mated to wild-type C57BL6 mice to generate F1 offspring
carrying the recombinant Atp7a allele. The neomycin cassette was
then removed by cross breeding the F1 mice with C57BL6 mice
expressing FLP recombinase to generate males and females
harboring the floxed Atp7a allele, hereafter designated Atp7afl
(Figure 1).
Global knockout of the Atp7a gene
To test whether Cre recombinase-mediated excision of exon 11
would generate a null allele of Atp7a, we crossed heterozygous
floxed females (Atp7afl/+) with mice that express Cre recombinase
early in development throughout the epiblast by embryonic
day 6.5 (E6.5) driven from the endogenous Claudin 6 gene
promoter (Cldn6Cre+/+). An absence of Atp7afl/Y; Cldn6Cre+/2
hemizygous male pups among a total of 80 live births suggested
that this genotype was embryonic lethal (Table 1), and was
consistent with our finding of only half the expected ratio of
Atp7afl/+; Cldn6Cre+/2 heterozygous females among these offspring.
Of the 16 Atp7afl/+; Cldn6Cre+/2 female pups, only two lived
beyond the second day of birth and these survivors exhibited
a mosaic pattern of hypopigmented coat coloring (Figure 2A and
2B), which was reminiscent of the variable pattern of X-
chromosome inactivation that gives rise to the variegated coat
color in heterozygous female carriers of Mottled mutations [12].
These females also exhibited curly whiskers (pili torti) (Figure 2C),
a well-documented feature of copper deficiency in the male
hemizygous Mottled mutants [13]. Taken together, these results
suggest that global excision of exon 11 of the Atp7a gene results in
embryonic lethality in male hemizygotes, and a partially dominant
haploinsufficiency in heterozygous females.
To verify that the absence of Cre-positive floxed males among
live births was not due to a failure of conception, embryos were
collected and genotyped at E10.5. Of a total of 64 embryos
analyzed, 13 were identified as Cre-positive floxed males (Atp7afl/Y;
Cldn6Cre+/2), which was close to the expected Mendelian ratio of
25% (Table 1). PCR analysis of the yolk sac DNA confirmed
highly efficient cleavage of exon 11 in the male hemizygous
Atp7afl/Y; Cldn6Cre+/2 embryos, and the presence of both wild type
and cleaved alleles in heterozygous Atp7afl/+; Cldn6Cre+/2 embryos
(Figure 3A). Immunoblot analysis demonstrated an absence of
Atp7a protein in the male hemizygous Atp7afl/Y; Cldn6Cre+/2
embryos (Figure 3B), and, as expected, the extent of this
reduction was variable in Atp7afl/+; Cldn6Cre+/2 heterozygous
female embryos (Figure 3B). The E10.5 male knockout embryos
were smaller than wild type sibling embryos, and exhibited striking
morphological defects in the frontonasal region and the orienta-
tion of the tail bud (Figure 4A). There was also a notable absence
of a blood-filled vascular network in the knockout embryo and the
surrounding yolk sac (Figure 4A and 4B). These findings
confirmed the essentiality of Atp7a in embryonic development and
establish a conditional knockout mouse model of this gene.
Characterization of wild type and knockout embryonic
fibroblasts
Cell clones in which the presence or absence of a given protein
is the sole genetic variable can often provide a powerful in vitro
model for understanding its cellular function. To develop such
a model for ATP7A, wild type mouse embryonic fibroblasts were
obtained from E13.5 Atp7afl/Y floxed male embryos and then
immortalized by transfection of a plasmid encoding the SV40
large T antigen. A single clone, MEF7a+, was obtained after
neomycin selection in which the Atp7a protein was detected by
immunoblotting (Figure 5A). Stable MEF7a2 derivatives of this
cell line lacking expression of the Atp7a protein were cloned by
transient transfection of MEF7a+ cells with a plasmid encoding
Cre recombinase to excise Exon 11 of the Atp7a gene (Figure 5A).
Since Atp7a mediates the transport of copper from the cytoplasm
into the Golgi, we investigated whether this function was lacking in
Figure 1. Schematic representation of the Atp7a gene-target-
ing strategy. Exons 8–13 of the wild type and recombinant Atp7a
locus are shown. The targeting construct included LoxP sites (black
triangles) that flanked exon 11 and a PGKneo gene cassette flanked by
FRT sites (grey triangles). The PGKneo gene cassette was removed by
crossbreeding with the ACT-FLPe deleter strain expressing FLP1
recombinase to generate mice with the desired floxed allele (Atp7afl).
The exon 11-deleted Atp7a allele (Deleted) is depicted following
excision by Cre recombinase, which was detected using PCR primers P1
and P2.
doi:10.1371/journal.pone.0043039.g001
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MEF7a2 cells. Transfection of a plasmid encoding tyrosinase, an
enzyme that requires copper loading within the secretory pathway
via the Atp7a protein [14], resulted in the production of the
DOPAchrome pigment in MEF7a+ cells, but not in MEF7a2 cells
(Figure 5B). The failure to produce DOPAchrome in MEF7a2
cells was due to a lack of Atp7a-mediated copper delivery to
tyrosinase because DOPAchrome was produced when MEF7a2
cells were co-transfected with both tyrosinase and ATP7A
expression plasmids (Figure 5B). Additional studies demonstrated
that the activity of a copper-inducible luciferase reporter plasmid
was higher following transfection of MEF7a2 cells relative to
MEF7a+ cells, consistent with higher cytoplasmic copper levels
resulting from the loss of Atp7a protein (Figure 5C). This was
further supported by the finding of lower levels of the Ccs protein
in MEF7a2 cells relative to MEF7a+ cells (Figure 5D), a protein
whose abundance is inversely proportional to copper concentra-
tion [15,16].
Discussion
The striking morphological and vascular defects observed in
Atp7afl/Y; Cldn6Cre+/2 embryos at E10.5 resembled the phenotype
of the most severe Mottled mutant in which embryonic lethality
Figure 2. Characterization of Atp7afl/+; Clnd6Cre+/2 heterozy-
gous female mice. A) Patches of hypopigmentation are observed in
the coats of weanling heterozygous Atp7afl/+; Clnd6Cre+/2 females. B)
Kaplan-Meier plot showing postnatal survival of heterozygous Atp7afl/+;
Clnd6Cre+/2 female (n = 16) and littermate control Atp7a+/+; Clnd6Cre+/2
(n = 34). C) Pili torti of the whiskers in surviving Atp7afl/+; Clnd6Cre+/2
females is shown (arrow).
doi:10.1371/journal.pone.0043039.g002
Table 1. Frequency of offspring with global deletion of the
Atp7a gene.
Genotype Live births E10.5 Expected
Atp7a+/Y; Cldn6Cre+/2 30 17 25%
Atp7afl/Y; Cldn6Cre+/2 0 13 25%
Atp7afl/+; Cldn6Cre+/2 16 14 25%
Atp7a+/+; Cldn6Cre+/2 34 20 25%
Total 80 64 100%
The numbers of live-born offspring or embryos at day 10.5 post coitus (E10.5)
are shown for each genotype resulting from a cross between Atp7afl/+ females
and Atp7a+/Y; Cldn6Cre+/+ males.
doi:10.1371/journal.pone.0043039.t001
Figure 3. Exon 11 deletion in male hemizygous Atp7afl/Y;
Clnd6Cre+/2 embryos. A) PCR analysis with P1 and P2 primers of yolk
sac DNA of E10.5 embryos generated by crossing heterozygous floxed
female mice (Atp7afl/+) with Cldn6Cre mice (Atp7a+/Y; Cldn6Cre+/+). Cre-
mediated deletion of the floxed allele (floxed) was detected by the
presence of a 647 bp PCR product (Deleted). Sex was determined by
PCR amplification of yolk sac DNA to simultaneously detect the X-
chromosome-specific Jarid1c gene (331 bp) and the Y-chromosome-
specific Jarid1d gene (302 bp). B) Immunoblot detection of Atp7a
protein in E10.5 embryos. Blots were probed with anti-Atp7a antibody
(1:5000) followed by HRP-conjugated anti-rabbit antibody (1:5000).
Actin protein was detected on the same blot as a loading control.
doi:10.1371/journal.pone.0043039.g003
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occurs at a similar stage of gestation [10]. Thus, the results
presented in this study provide conclusive evidence that global
deletion of the Atp7a gene in mice results in embryonic lethality.
Although the precise biochemical basis for embryonic lethality in
mice lacking an intact Atp7a gene is unknown, the Atp7a protein is
known to deliver copper to at least three copper-containing
enzymes whose deletion has been shown to cause lethality during
gestation or the perinatal period, including peptidyl-glycine alpha-
amidating monooxygenase, dopamine beta hydroxylase and lysyl
oxidase [17–19]. Thus, it is reasonable to conclude that the
phenotype of Atp7afl/Y; Cldn6Cre+/2 embryos is likely to stem from
hypoactivity of these enzymes, and possibly others that acquire
copper via the secretory pathway. It was also interesting to note
that while heterozygous deletion of Atp7a in our study generated
a high rate of postnatal mortality, heterozygous Mottled females
are viable and able to propagate even the embryonic lethal
Mottled mutations [11]. We speculate that the more severe
phenotype in our heterozygous females may be due to the C57BL6
mouse background on which Atp7a mutations are known to be
more severe than on other inbred strains [10,20].
The floxed mouse model and the approaches used in this study
will provide a powerful tool for deciphering the physiological
importance of Atp7a protein in a spatiotemporal context. As there
are currently no effective treatments for Menkes disease, occipital
horn syndrome or SMAX3, deciphering the phenotypic of
consequences tissue-specific Atp7a deletion may lead to new
therapies for these disorders. Questions that we hope to address
with this new animal model include the extent to which the
neurological abnormalities in Menkes disease arise from a lack of
copper delivery from the blood into the brain, versus a lack of
ATP7A within the brain itself. Understanding such distinctions
may have important implications for the development of
membrane-permeable copper complexes able to carry copper
ions across the blood brain barrier [21,22], or the design of viral
vectors that direct the expression of an ATP7A transgene in specific
cell types of the brain in which a deficiency of Atp7a protein
generates for the most severe neurological defects [20]. Addressing
the requirement for Atp7a in motor neurons may shed light on the
neuromuscular abnormality in patients with SMAX3. Of partic-
ular interest is whether SMAX3-like motor defects arise from
copper toxicity in the motor neuron or a reduced copper delivery
to cuproenzymes of the secretory pathway.
Notwithstanding the importance of ATP7A in these genetic
disorders, numerous studies have also implicated ATP7A in a wide
range of highly specialized processes beyond cellular copper
homeostasis including glutamateric signaling and synaptogenesis
in neurons [23,24], macrophage bactericidal activity [25],
oxidation of low density lipoprotein particles [26], smooth muscle
migration [27], Alzheimer’s disease [28], and multidrug resistance
in cancer cells [29,30]. Thus, the ability to selectively delete Atp7a
in a tissue-specific manner may provide new insights into the
broader roles of copper in normal physiology and disease states.
Materials and Methods
Animals and ethics
All animal husbandry and euthanasia procedures were per-
formed in accordance with and under the approval of the Animal
Care and Use Committee of the University of Missouri. All mice
were on the C57BL6 strain background. Mice were maintained on
12 hour light-dark cycle and food and water provided ad libitum.
Picolab diet 5053 (13 ppm Cu) was provided to mice at weaning
and Picolab diet 5058 (17 ppm Cu) was provided during
pregnancy and lactation (PMI International, St. Louis, MO,
USA).
Generation of the Atp7a floxed mouse
Portions of the floxed mouse production were performed under
contract by inGenious Targeting Laboratory, INC (Stonybrooke,
NY). A 9.7 kb PvuII restriction fragment from a bacterial artificial
chromosome library of C57BL6 mouse genomic DNA (clone
RPC1-23-186F4) encompassing exons 8 to 13 of the Atp7a gene
was subcloned into the pSP72 vector (Promega). A 62 bp single
loxP cassette was inserted at a unique KpnI site located 123 bp
upstream of the 59 splice boundary of exon 11. A neomycin
cassette flanked by LoxP and FRT sites was excised from the
plasmid pGK-gb2 loxP/FRT Neo (Gene Bridges GmbH,
Germany) and inserted 313 bp downstream of the 39 splice exon
11 at unique BamHI site. The targeting vector was confirmed by
sequencing. Ten micrograms of the targeting vector was linearized
by NotI digestion and electroporated into C57BL/6 embryonic
stem cells (Taconic, Hudson, NY), and single clones were selected
for resistance to G418. Cell clones containing homologous
insertion of long and short arms of the targeting vector were
confirmed by southern blot and PCR analysis, and sequencing
across LoxP sites and exons was used to verify fidelity of
integration. Five independent correctly targeted clones were
microinjected into Balb/c blastocysts and resulting chimeras with
a high percentage black coat color were mated to wild-type
C57BL6 mice to generate F1 offspring. Removal of the neomycin
cassette via excision of flanking FRT sites was achieved by cross-
breeding to FLP recombinase-expressing mice (strain B6.Cg-
Tg(ACTFLPe)9205 Dym/J; Jackson Laboratory, Bar Harbor,
ME). Floxed mice lacking the Neo cassette were identified by
PCR analysis of tail genomic DNA and maintained on the
C57BL6J background.
Figure 4. Morphological and vascular abnormalities in male
hemizygous Atp7afl/Y; Clnd6Cre+/2 embryos. A) Developmental
anomalies particularly in the frontonasal region and tail bud orientation
were apparent in the Atp7afl/Y; Cldn6Cre+/2 embryos at E10.5. B) The
blood-filled vascular network observed in wild type embryos and yolk
sacs (arrowheads) was lacking for the Atp7afl/Y; Cldn6Cre+/2.
doi:10.1371/journal.pone.0043039.g004
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Conditional knockout of Atp7a
To generate the global knockout, Atp7Afl/+ females were
crossbred with Cldn6tm1(cre)Dkwu/J mice (Jackson Laboratory). Tail
snips from offspring were genotyped using PCR primers P1 (59-
GACAATACTACACTGACCATATTCA -39) and P2 (59-
GTTCCACAGAAACTATATGCCTGGG -39). Detection of
the Cre recombinase transgene was achieved using primers CreF
(59- GATCGCTGCCAGGATATACG -39) and CreR (59-
AATCGC CATCTTCCAGCAG -39). Timed pregnancy was
established by confirmation of a copulation plug in female mice
the morning after introduction to a breeding male, and this was
designated as embryonic day E0.5 of pregnancy. At day E10.5,
embryos were isolated from pregnant dams and the yolk sacs were
Figure 5. Characterization of MEF7a+ and MEF7a2 cells. A) Immunoblot analysis of Atp7a protein in MEF7a+ and MEF7a2 cells. Blots were
probed with anti-Atp7a antibody (1:5000) followed by HRP-conjugated anti-rabbit antibody (1:5000). B) Defective copper delivery to tyrosinase
MEF7a2 cells. MEF7a+ and MEF7a2 cells were transiently transfected with a plasmid encoding tyrosinase (pcTYR) alone, or in combination with
a plasmid encoding ATP7A (pATP7A). Cells were then fixed in methanol and incubated with L-DOPA to allow the formation of the brown pigment,
DOPAchrome. Note the absence of tyrosinase activity in MEF7a2 cells transfected with pcTYR alone (left), and complementation of this defect by co-
transfection of pcTYR and pATP7A (right). C) MEF7a+ and MEF7a2 cells were transiently transfected with a Metal Responsive Element (MRE) reporter
plasmid and a Renilla expression plasmid (pRL) as an internal control. After 24 hours, MRE luciferase activities of cell lysates were measured and
normalized for Renilla luciferase activities. Experiments were repeated at least three times and values are presented as fold induction 6 SEM;
*p,0.05. D). Immunoblot analysis of Ccs protein in MEF7a+ and MEF7a2 cells. Blots were probed with anti-CCs antibody (1:500) followed by HRP-
conjugated anti-rabbit antibody (1:5000).
doi:10.1371/journal.pone.0043039.g005
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separated for genotyping as described above. Sex determination
was performed as described previously [31].
Immunoblotting
Tissue samples and embryos were homogenized in ice-cold
phosphate buffered saline (PBS) at pH 7.4, and protein lysates
were prepared by sonicating cell pellets in lysis buffer containing
2.5 mM Tris–HCl (pH 7.4), 2% sodium dodecyl sulfate, 1%Tri-
ton X-100, 1 mM EDTA and CompleteTM protease inhibitor
(Roche Molecular Biochemicals, Indianapolis, IN). Protein lysates
were fractionated by 7.5% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and transferred onto nitrocellulose membranes.
The membranes were blocked with 1% casein solution and
incubated in blocking buffer at 4uC overnight with a rabbit anti-
Atp7a antibody, described previously [32], raised against the
terminal 20 amino acids (1:5000 dilution) or mouse b-actin
antibody (1:5000) (abcam, Cambridge, MA). Horseradish perox-
idase conjugated goat anti-rabbit IgG or goat anti-mouse IgG
(1:5000) were used as secondary antibodies, and blots were
developed using the SuperSignal West Pico Substrate according to
the manufacturer’s instructions (Pierce, Rockford, IL).
Isolation and Culture of Mouse Embryonic Cells
Hemizygous male floxed embryos (Atp7afl/Y) were dissected from
the decidua at embryonic day 13.5 and all tissues remaining after
removal of the head and internal organs were minced with scissors
and then incubated in 0.25% trypsin at 37uC for 15 minutes to
facilitate dispersal into a single cell suspension. The cells were then
cultured in complete medium (Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum, 2 mM
glutamine and 100 units/ml penicillin and streptomycin). After
3 weeks of culture, the cells were passaged onto 100 mm dishes
and transfected with the pSV3-neo plasmid carrying SV40 large T
antigen gene using the LipoD293 transfection reagent (SignaGen,
Rockville, MD), and selected for resistance to neomycin. Single
colonies were then expanded to generate multiple immortalized
MEF7a+ cell lines. To generate an isogenic cell line lacking Atp7a
protein expression (MEF7a2 cells), the Atp7a gene was deleted by
transient transfection of one MEF7a+ cell clone with a plasmid
carrying the Cre recombinase gene fused to GFP (pCAG-Cre:
GFP; Addgene, Cambridge, MA). Cells enriched for GFP
expression were sorted into 96 well trays by fluorescence activated
cell sorting, and single clones were expanded. Deletion of the Atp7a
gene was confirmed by PCR genotyping.
Luciferase Reporter Assay
MEF7a+ and MEF7a2 cells were seeded in 96-well plates and
transiently transfected with 35 ng of the MRE-luciferase reporter
[33], and 3.5 ng of Renilla luciferase plasmid (pRL) using
LipoD293 transfection reagent (SignaGen Laboratories). After
a 24-hour incubation in complete medium, the firefly luciferase
activity and Renilla luciferase activity were assayed by lumin-
ometer (Veritas) using the Dual-Glo luciferase assay system
(Promega, Madison, WI). The relative light units (RLU) were
calculated by dividing firefly luciferase activity by Renilla
luciferase activity. Fold induction was calculated as mean RLU
produced by MEF7a2 cells divided by mean RLU produced by
MEF7a+ cells.
In Situ Tyrosinase Activity Assay
In situ tyrosinase activity was conducted in MEF cells as
previously described by detecting the formation of brown DOPA-
chrome from the oxidation of colorless L-DOPA [14].
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